Leonteq AG (XSWX:LEON) Cash per Share

: CHF264.11 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Leonteq AG's Cash per Share for the quarter that ended in Dec. 2023 was CHF264.11.

Leonteq AG Cash per Share Historical Data

The historical data trend for Leonteq AG's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Leonteq AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash per Share

Get a 7-Day Free Trial

194.37

306.59

289.02

276.83

264.11

Leonteq AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash per Share	Get a 7-Day Free Trial															289.02	350.60	276.83	271.36	264.11

Leonteq AG Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Leonteq AG's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	4636.698	/	17.6
	=	264.11

Leonteq AG's Cash per Share for the quarter that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	4636.698	/	17.6
	=	264.11

Leonteq AG (XSWX:LEON) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Leonteq AG Cash per Share Related Terms

Thank you for viewing the detailed overview of Leonteq AG's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Leonteq AG (XSWX:LEON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Leonteq AG (XSWX:LEON) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

LEONz:UK LEONE:Switzerland

Address

Europaallee 39, Zurich, CHE, 8004

Website

https://www.leonteq.com

Leonteq AG is a Swiss fintech company with a marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees. The company has a presence in its home market of Switzerland and Europe, as well as an established footprint in Asia.

Leonteq AG (XSWX:LEON) Headlines

From GuruFocus

Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired • 03-29-2018

Leone Asset Management's Subsidiary JP Anderson Signs MOU

By ACCESSWIRE • 09-20-2023

Leone Asset Management Releases Q1 Update

By ACCESSWIRE ACCESSWIRE • 04-11-2023

Leone Asset Management Signs Joint Venture

By ACCESSWIRE ACCESSWIRE • 04-20-2023

Leone Asset Management Signs Letter of Intent to Acquire New Energy Solutions

By ACCESSWIRE ACCESSWIRE • 07-18-2022

UPDATE: Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired • 03-29-2018